JENNIFER NUSPEL: Open Payments
NPI 1093176174 · DENTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 18 payments from 9 companies in 2025. Trend: 2023 $779 · 2024 $418 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $135 |
| Sage Therapeutics, LLC | 5 | $86 |
| MILLICENT US INC | 3 | $62 |
| Exeltis, USA Inc. | 2 | $35 |
| Supernus Pharmaceuticals, Inc. | 2 | $34 |
| Organon LLC | 1 | $29 |
| Hologic Sales and Service, LLC | 1 | $24 |
| CooperSurgical, Inc. | 1 | $18 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $2 |
Products named: Veozah, ZURZUVAE, FEMLYV, SLYND, Qelbree, NEXPLANON, INTRAROSA, THINPREP 2000 PROCESSOR.
Industry payments across TX — which companies pay providers there.
